Chemours
488 hedge funds and large institutions have $3.12B invested in Chemours in 2019 Q2 according to their latest regulatory filings, with 57 funds opening new positions, 138 increasing their positions, 172 reducing their positions, and 101 closing their positions.
0.44% less ownership
Funds ownership: 79.86% → 79.42% (-0.44%)
9% less funds holding
Funds holding: 539 → 488 (-51)
13% less funds holding in top 10
Funds holding in top 10: 8 → 7 (-1)
20% less repeat investments, than reductions
Existing positions increased: 138 | Existing positions reduced: 172
37% less capital invested
Capital invested by funds: $4.92B → $3.12B (-$1.8B)
40% less call options, than puts
Call options by funds: $65.8M | Put options by funds: $109M
44% less first-time investments, than exits
New positions opened: 57 | Existing positions closed: 101
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GC
Greenlight Capital
New York
|
+$110M |
| 2 |
TP
Third Point
New York
|
+$70M |
| 3 |
SC
Sessa Capital
New York
|
+$65.5M |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$59M |
| 5 |
Goldman Sachs
New York
|
+$51.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IAM
Iridian Asset Management
Westport,
Connecticut
|
-$287M |
| 2 |
First Eagle Investment Management
New York
|
-$69.7M |
| 3 |
MWA
Marshall Wace Asia
Central,
Hong Kong
|
-$60.7M |
| 4 |
GAM
Gotham Asset Management
New York
|
-$49.3M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$40M |
CC Hedge Fund Activity: Q2 2019 in Review
488 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Chemours (CC) for Q2 2019, worth a combined $3.12B — down 37% from $4.92B a quarter earlier.
Sellers outnumbered buyers: 101 funds closed out of CC and 57 opened new positions — a net loss of 44 holders — while 172 trimmed existing stakes and 138 added.
The largest buyer was Greenlight Capital, opening a new position worth an estimated $110M. The largest seller was Iridian Asset Management, exiting entirely with an estimated $287M sold.
- 488 institutional investors held Chemours (CC) as of Q2 2019, down from 539 in Q1 2019.
- Funds reported $3.12B of Chemours stock for Q2 2019, down 37% quarter-over-quarter.
- 57 funds opened new Chemours positions in Q2 2019 and 101 closed out, a net change of -44 holders.
- The largest Chemours buyer in Q2 2019 was Greenlight Capital, an estimated $110M added.
- The largest Chemours seller in Q2 2019 was Iridian Asset Management, an estimated $287M sold.
Based on aggregated 13F filings for Q2 2019.